Skip to main content
. 2012 Apr 13;61(5):1153–1159. doi: 10.2337/db11-1271

FIG. 5.

FIG. 5.

Survival of MSCs modified with genes and secretion of VEGF and FGF-2 by transplanted MSCs in diabetic ischemic hindlimb. A: The GFP-positive MSCs (per 1,000 nuclei) in ischemic muscles of the PGC-1α-MSC group 5 days after transplantation were significantly higher than those in the GFP-MSC group. *P < 0.001. B: Western blotting analysis for VEGF, FGF-2, and GAPDH 5 days after transplantation. C: Secretion of FGF-2 and VEGF by transplanted MSCs that were modified with genes. Colocalization of GFP-positive MSCs (green) with VEGF (red) or GFP-positive MSCs (green) with FGF-2 (red) in ischemic muscles 5 days after transplantation. Scale bars, 10 μm. (A high-quality color representation of this figure is available in the online issue.)